Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study

Clinical Endocrinology

Volumn 49, Issue 4, 1998, Pages 451-457

  Benker, Georg ^a,e   Reinwein, Dankwart ^a   Kahaly, Georg ^b   Tegler, Lennart ^c   Alexander, W Donald ^d   Faßbinder, Johanes ^a   Hirche, Herbert ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c LINKÖPING UNIVERSITY   (Sweden)

^d WESTERN INFIRMARY   (United Kingdom)

^e MERCK KGAA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IODIDE; LEVOTHYROXINE; LIOTHYRONINE; THIAMAZOLE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ECHOGRAPHY; EUROPE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; THYROID WEIGHT; TREATMENT OUTCOME; URINARY EXCRETION;

ADULT; ANTITHYROID AGENTS; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; METHIMAZOLE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0031668462     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00554.x     Document Type: Article

References (29)

1. Allanic, H., Fauchet, R., Orgiazzi, J., Madec, A.M., Genetet, B., Lorcy, Y., Leguerrier, A.M., Delambre, C. & Derennes, V. (1990) Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration. Journal of Clinical Endocrinology and Metabolism, 70, 675-679.
2. Benker, G., Vitti, P., Kahaly, G., Raue, F., Tegler, L., Hirehe, H. & Reinwein, D. (1945) Response to methimazole in Graves' disease. The European Multicentre Study Group. Clinical Endocrinology, 43, 257-263.
3. Codaccioni, J.L., Orgiazzi, J., Blanc, P., Pugeat, M., Roulier, R. & Carayon, P. (1988) Lasting remission in patients treated for Graves' hyperthyroidism with propranolol alone: a pattern of spontaneous evolution of the disease. Journal of Clinical Endocrinology and Metabolism 67, 656-662.
4. Cooper, D.S. (1991) Treatment of thyrotoxicosis. In Werner and Ingbar's The Thyroid. A fundamental and clinical text (eds L.E. Bravermun & R.D. Utiger), pp. 867-916. J. B. Lippincott, Philadelphia.
5. Crooks, J., Murray, I.P.C. & Wayne, E.J. (1959) Statistical methods applied to the diagnosis of thyrotoxicosis. Quarterly Journal of Medicine, 28, 211-234.
6. Escobar-Morreale, H.F., Serrano-Gotarredona, J., Villar, L.M., Garcia-Robles, R., Gonzalez-Porque, P., Sancho, J.M. & Varela, C. (1996) Methimazole has no dose-related effect on the serum concentrations of soluhle class 1 major histocompatibility complex antigens, soluble inteleukin-2 receptor, and heta 2-microglobulin in patients with Graves' disease. Thyroid, 6, 29-36.
7. Feldt-Rasmussen, U., Schleusener, H. & Carayon, P. (1994) Metaanalysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease. Journal of Clinical Endocrinology and Metabolism, 78, 98-102.
8. Garcia-Mayor, R.V., Paramo, C., Luna Cano, R., Perez Mendez, L.F., Galofre, J.C. & Andrade, A. (1992) Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission. Journal of Endocrinological Investigation, 15, 815-820.
9. Hashizume, K., Ichikawa, K., Sakurai, A., Suzuki, S., Takeda, T., Kobayashi, M., Miyamoto, T., Arai, M. & Nagasawa, T. (1991) Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. New England Journal of Medicine, 324, 947-953.
10. Hashizume, K., Ichikawa, K., Nishii, Y., Kobayashi, M., Sakurai, A., Miyamoto, T., Suzuki, S. & Takeda, T. (1992) Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease. Journal of Clinical Endocrinology and Metabolism, 75, 6-10.
11. Hedley, A.J., Young, R.E., Jones, S.J., Alexander, W.D. & Bewsher, P.D. (1989) Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long-term follow-up of 434 patients. Scottish Automated Follow-Up Register Group. Clinical Endocrinology, 31, 209-218.
12. Jorde, R., Ytre-Ame, K., Stormer, J. & Sundsfjord, J. (1995) Short-term treatment of Graves' disease with methimazole in high versus low doses. Journal of Internal Medicine, 238, 161-165.
13. Leclère, J. (1994) Traitement de la maladie de Basedow par antithyroidiens de synthèse. Evaluation de la dose sur l'efficacité du traitement à long terme. Annals d'Endocrinologie (Paris), 55, 11-14.
14. Mazzeferri, E.L., Reynolds, J.C., Young, R.L., Thomas, C.N. & Parisi, A.F. (1976) Propranolol as primary treatment for thyrotoxicosis. Archives of Internal Medicine, 130, 50-56.
15. McIver, B., Rae, P., Beckett, G., Wilkinson, E., Gold, A. & Toft, A. (1996) Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug (see comments). New England Journal of Medicine, 334, 220-224.
16. McLarty, D.G., Brownlie, B.E.W., Alexander, W.D., Papapetrou, P.D. & Horton, P. (1973) Remission of thyrotoxicosis during treatment with proprunolol. British Medical Journal, ii, 332-334.
17. Meng, W., Meng, S., Maennchen, E., Hampel, R., Kirsch, G., Dannenberg, J. & Krabbe, S. (1991) Effect of therapy duration and low and highly dosed thiamazole treatment in Basedow's-Graves' disease. Experimental and Clinical Endocrinology and Diabetes, 97, 257-260.
18. Meyer-Gessner, M., Benker, G., Lederbogen, S., Olbricht, T. & Reinwein, D. (1994) Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. Journal of Endocrinological Investigation, 17, 29-36.
19. Paschke, R., Vogg, M., Kristoferitsch, R., Aktuna, D., Wawschinek, O., Eber, O. & Usadel, K.H. (1995) Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves' disease. Journal of Clinical Endocrinology and Metabolism, 80, 2470-2474.
20. Pimstone, B., Joffe, B., Pimstone, N., Bonnici, F. & Jackson, W.P.U. (1969) Clinical response to longterm propranolol therapy in hyperthyroidism. South African Medical Journal, 43, 1203-1205.
21. Reinwein, D., Benker, G., Lazarus, J.H. & Alexander, W.D. (1993) A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicentre Study Group on Antithyroid Drug Treatment. Journal of Clinical Endocrinology and Metabolism, 76, 1516-1521.
22. Rittmaster, R.S., Zwicker, H., Abbott, E.C., Douglas, R., Givner, M.L., Gupta, M.K., Lehmann, L., Reddy, S., Salisbury, S.R., Shlossberg, A.H., Tan, M.H. & York, S.E. (1996) Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease. Journal of Clinical Endocrinology and Metabolism, 81, 3283-3288.
23. Romaldini, J.H., Bromberg, N., Werner, R.S., Tanaka, L.M., Rodrigues, H.F., Werner, M.C., Farah, C.S. & Reis, L.C. (1983) Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 57, 563-570.
24. SAS Institute (1996) SAS/STAT™ Software: changes and enhancements through release 6.11, pp. 807-872. SAS Institute, Cary, NC.
25. Tamai, H., Hayaki, I., Kawai, K., Komaki, G., Matsubayashi, S., Kuma, K., Kumagai, L.F. & Nagataki, S. (1995) Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. Journal of Clinical Endocrinology and Metabolism, 80, 1481-1484.
26. Vitti, P., Rago, T., Chiovato, L., Pallini, S., Santini, F., Fiore, E., Rocchi, R., Martino, E. & Pinchera, A. (1997) Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid. 7, 639-675.
27. Wartofsky, L. (1973) Low remission after therapy for Graves' disease. Possible relation of dietary iodine with antithyroid therapy results. Journal of the American Medical Association, 226, 1083-1088.
28. Weetman, A.P., Pickerill, A.P., Watson, P., Chatterjee, V.K. & Edwards, O.M. (1994) Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse. Quarterly Journal of Medicine, 87, 337-341.
29. Weetman, A.P. & McGregor, A.M. (1994) Autoimmune thyroid disease: further developments in our understanding. Endocrine Reviews, 15, 788-830.